Cartesian Therapeutics, Inc. Common Stock
RNAC •
Sell Open
Signal type
Sell
Status
Open
Open Price
$6.05
Stop Loss
$9.09
Performance
-4.92%
Days Open
22
Signal Setup
Signal Type Sell
Status Open
Open Date Mar 24, 2026
Open Price $6.05
Stop Loss $9.09
Timespan Day
Company Profile
Name Cartesian Therapeutics, Inc. Common Stock
Ticker RNAC
Market Cap $269.67M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $6.35
List Date Jun 22, 2016
Description
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
Website Open Company Website